49-20-420. Coverage for in vitro fertilization and genetic testing.
(1) As used in this section:
(a) "Qualified condition" means:
(i) cystic fibrosis;
(ii) spinal muscular atrophy;
(iii) Morquio Syndrome;
(iv) myotonic dystrophy; or
(v) sickle cell anemia.
(b) "Qualified individual" means a covered individual who:
(i) has been diagnosed by a physician as having a genetic trait associated with a qualified condition; and
(ii) intends to get pregnant with a partner who is diagnosed by a physician as having a genetic trait associated with the same qualified condition as the covered individual.
(2) For a plan year that begins on or after July 1, 2020, the program shall provide coverage for a qualified individual for:
(a) in vitro fertilization services; and
(b) genetic testing of a qualified individual who receives in vitro fertilization services under Subsection (2)(a).
(3) Before November 1, 2022, and before November 1 of every third year thereafter, the program shall:
(a) calculate the change in state spending attributable to the coverage under this section; and
(b) report the amount described in Subsection (3)(a) to the Health and Human Services Interim Committee and the Social Services Appropriations Subcommittee.